https://www.selleckchem.com/HSP-90.html
328, 95% CI [0.149, 0.507], P .001), craving (SMD = 0.274, 95% CI [0.103, 0.446], P = .002), and the reduction in the frequency of ADHD symptoms (SMD = 0.420, 95% CI [0.259, 0.582], P .001). The pooled effect was moderate for the management of withdrawal symptoms (SMD = 0.577, 95% CI [0.389, 0.764], P = .001]) and the decrease in the severity of ADHD symptoms (SMD = 0.533, 95% CI [0.393, 0.672], P .001). The magnitude of benefits for pharmacological interventions varies. Despite some limitations, it was positive. This meta-analysis
Like
Comment
Share
